SCHEMBL25757085

SCHEMBL25757085

CNc1cc[nH]c(=O)c1C(=N)I

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.32
ROCK2 O75116 1/20 0.31
EGFR P00533 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623570 0.75 PARP1 (0.31) PARP1
SCHEMBL31701620 0.70 CYP1A2 (0.35) PARP1ROCK2
SCHEMBL31701724 0.68 PARP1 (0.33) PARP1ROCK2
SCHEMBL22216142 0.68 TSHR (0.33)
SCHEMBL17849234 0.66 JAK2 (0.38) ROCK2
SCHEMBL31700720 0.66 KDM4E (0.35) PARP1EGFR
SCHEMBL25757086 0.65 CRBN (0.34)
SCHEMBL10094591 0.63
SCHEMBL3652772 0.61 NAPRT (0.41) PARP1ROCK2EGFR
SCHEMBL3649191 0.61 KDM4E (0.41) PARP1ROCK2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109954-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2023-06-22 WO disclosed